Academic
Publications
Selectivity to amyloid-β precursor protein cleavage provides hope against Alzheimer's

Selectivity to amyloid-β precursor protein cleavage provides hope against Alzheimer's,10.1186/alzrt66,Alzheimer's Research & Therapy,Taisuke Tomita,Ph

Selectivity to amyloid-β precursor protein cleavage provides hope against Alzheimer's  
BibTex | RIS | RefWorks Download
Toward development of a safe and effective treatment for Alzheimer's disease, Elan Pharmaceuticals reported a novel γ-secretase inhibitor that specifically targets the cleavage of amyloid-β precursor protein, opening the way to design of substrate-specific γ-secretase inhibitors that would reduce the amyloid burden without significant adverse events.
Journal: Alzheimer's Research & Therapy - Alzheimers Res Ther , vol. 3, no. 2, pp. 1-2, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.